1. Guidelines to assure the Quality, safety and efficacy of recombinant Human papillomavirus virus-like particle vaccines, Adopted by: WHO Expert Committee on Biological Standardization, Fifty-seventh meeting. Geneva: World Health Organization, 2006 (WHO Technical Report Series, in press.) Available on: http://www.who.int/biologicals/publications/trs/areas/vaccines/human_papillomavirus/HPVg%20Final%20BS%202050%20.pdf.
2. Regulation of vaccines: building on existing drug regulatory authorities, Department of Vaccines and other Biologicals. Geneva: World Health Organization, 1999, Available on: WHO/V&B/99.10. http://whqlibdoc.who.int/hq/1999/WHO_V&B_99.10.pdf. Revised in June 2004, Available on: http://www.who.int/immunization_standards/national_regulatory_authorities%20/vaccine_indicators/en/index.html/.
3. Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR;Van Doorn;J Clin Microbiol,2006
4. Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16 and 18 by a multiplexed luminex assay;Opalka;Clin Diagn Lab Immunol,2003